FDA News

Latest News

FDA logo black and white | Credit: US Food and Drug Administration
Tobevibart, Elebsiran Receive FDA Breakthrough Therapy Designation for Chronic HDV

December 12th 2024

The FDA awarded Breakthrough Therapy Designation to Vir Biotechnology’s tobevibart and elebsiran for the treatment of chronic hepatitis delta.

FDA logo black and white | Credit: US Food and Drug Administration
FDA Finds Obeticholic Acid (Ocaliva) Linked to Serious Liver Injury in Noncirrhotic PBC

December 12th 2024

FDA News Month in Review: November 2024
FDA News Month in Review: November 2024

December 7th 2024

FDA I Image Credit: FDA
Intra-Cellular Therapies Submits sNDA to FDA for Lumateperone as an MDD Adjunctive Therapy

December 3rd 2024

FDA Authorizes Predetermined Change Control Plan for Sleep Wearable Dreem 3S
FDA Authorizes Predetermined Change Control Plan for Sleep Wearable Dreem 3S

December 3rd 2024

Video Interviews
Podcasts
Brian Hansen | Credit: Ascensia Diabetes Care
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.
Thumbnail featuring podcast hosts and logo for Diabetes Dialogue

More News

© 2024 MJH Life Sciences

All rights reserved.